CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Common Stock | Additional Paid-in Capital | Retained Deficit | Accumulated Other Comprehensive (Loss) Income | Total |
Balance at beginning of period at Dec. 31, 2019 | $ 233 | $ 154,235 | $ (49,731) | $ (1,572) | $ 103,165 |
Balance at beginning of period (in shares) at Dec. 31, 2019 | 23,335,855 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net (loss) income | | | 993 | | 993 |
Unrealized income (loss) on foreign exchange rate translation | | | | (1,199) | (1,199) |
Stock-based compensation expense | | 203 | | | 203 |
Balance at end of period at Mar. 31, 2020 | $ 233 | 154,438 | (48,738) | (2,771) | 103,162 |
Balance at end of period (in shares) at Mar. 31, 2020 | 23,335,855 | | | | |
Balance at beginning of period at Dec. 31, 2019 | $ 233 | 154,235 | (49,731) | (1,572) | 103,165 |
Balance at beginning of period (in shares) at Dec. 31, 2019 | 23,335,855 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net (loss) income | | | | | (5,347) |
Balance at end of period at Sep. 30, 2020 | $ 235 | 154,763 | (55,078) | (1,793) | 98,127 |
Balance at end of period (in shares) at Sep. 30, 2020 | 23,526,517 | | | | |
Balance at beginning of period at Mar. 31, 2020 | $ 233 | 154,438 | (48,738) | (2,771) | 103,162 |
Balance at beginning of period (in shares) at Mar. 31, 2020 | 23,335,855 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net (loss) income | | | 1,500 | | 1,500 |
Unrealized income (loss) on foreign exchange rate translation | | | | 604 | 604 |
Issuance of common stock under stock compensation plans | $ 1 | (1) | | | |
Issuance of common stock under stock compensation plans (in shares) | 78,600 | | | | |
Stock-based compensation expense | | 271 | | | 271 |
Shares exchanged for taxes on stock-based compensation | | (17) | | | (17) |
Shares exchanged for taxes on stock-based compensation (in shares) | (15,420) | | | | |
Balance at end of period at Jun. 30, 2020 | $ 234 | 154,691 | (47,238) | (2,167) | 105,520 |
Balance at end of period (in shares) at Jun. 30, 2020 | 23,399,035 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net (loss) income | | | (7,840) | | (7,840) |
Unrealized income (loss) on foreign exchange rate translation | | | | 374 | 374 |
Issuance of common stock under stock compensation plans | $ 2 | (2) | | | |
Issuance of common stock under stock compensation plans (in shares) | 157,500 | | | | |
Stock-based compensation expense | | 126 | | | 126 |
Shares exchanged for taxes on stock-based compensation | $ (1) | (52) | | | (53) |
Shares exchanged for taxes on stock-based compensation (in shares) | (30,018) | | | | |
Balance at end of period at Sep. 30, 2020 | $ 235 | 154,763 | (55,078) | (1,793) | 98,127 |
Balance at end of period (in shares) at Sep. 30, 2020 | 23,526,517 | | | | |
Balance at beginning of period at Dec. 31, 2020 | $ 235 | 154,866 | (62,927) | (1,200) | $ 90,974 |
Balance at beginning of period (in shares) at Dec. 31, 2020 | 23,526,517 | | | | 23,478,072 |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net (loss) income | | | (5,228) | | $ (5,228) |
Unrealized income (loss) on foreign exchange rate translation | | | | 201 | 201 |
Stock-based compensation expense | | 101 | | | 101 |
Balance at end of period at Mar. 31, 2021 | $ 235 | 154,967 | (68,155) | (999) | 86,048 |
Balance at end of period (in shares) at Mar. 31, 2021 | 23,526,517 | | | | |
Balance at beginning of period at Dec. 31, 2020 | $ 235 | 154,866 | (62,927) | (1,200) | $ 90,974 |
Balance at beginning of period (in shares) at Dec. 31, 2020 | 23,526,517 | | | | 23,478,072 |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net (loss) income | | | | | $ (22,110) |
Balance at end of period at Sep. 30, 2021 | $ 237 | 155,101 | (85,037) | (1,095) | $ 69,206 |
Balance at end of period (in shares) at Sep. 30, 2021 | 23,692,379 | | | | 23,643,934 |
Balance at beginning of period at Mar. 31, 2021 | $ 235 | 154,967 | (68,155) | (999) | $ 86,048 |
Balance at beginning of period (in shares) at Mar. 31, 2021 | 23,526,517 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net (loss) income | | | (9,017) | | (9,017) |
Unrealized income (loss) on foreign exchange rate translation | | | | 211 | 211 |
Issuance of common stock under stock compensation plans | $ 2 | (2) | | | |
Issuance of common stock under stock compensation plans (in shares) | 174,000 | | | | |
Stock-based compensation expense | | 67 | | | 67 |
Issuance of common stock as compensation | | 30 | | | 30 |
Issuance of common stock as compensation (in shares) | 11,320 | | | | |
Shares exchanged for taxes on stock-based compensation | | (75) | | | (75) |
Shares exchanged for taxes on stock-based compensation (in shares) | (31,410) | | | | |
Balance at end of period at Jun. 30, 2021 | $ 237 | 154,987 | (77,172) | (788) | 77,264 |
Balance at end of period (in shares) at Jun. 30, 2021 | 23,680,427 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net (loss) income | | | (7,865) | | (7,865) |
Unrealized income (loss) on foreign exchange rate translation | | | | (307) | (307) |
Stock-based compensation expense | | 84 | | | 84 |
Issuance of common stock as compensation | | 30 | | | 30 |
Issuance of common stock as compensation (in shares) | 11,952 | | | | |
Balance at end of period at Sep. 30, 2021 | $ 237 | $ 155,101 | $ (85,037) | $ (1,095) | $ 69,206 |
Balance at end of period (in shares) at Sep. 30, 2021 | 23,692,379 | | | | 23,643,934 |